The U.S. government has awarded Moderna $590 million to advance the late-stage development of its mRNA bird flu vaccine, as ...

Moderna cut its 2025 sales forecast by $1 billion on Monday, hurt by a slow adoption of its respiratory syncytial virus (RSV) ...

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...

The US Department of Health and Human Services will award $590 million to Moderna to continue developing a vaccine to protect ...

CAMBRIDGE, MA / ACCESS Newswire / January 17, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced ongoing support from the U.S. Department of Health and Human Services (HHS) to accelerate the ...

Cases of norovirus infections are surging, but coming up with a way to prevent them has proven to be a challenge.

The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.

J.P. Morgan analyst Jessica Fye has maintained their bearish stance on MRNA stock, giving a Sell rating yesterday.Stay Ahead of the ...

Novavax (NVAX) and other vaccine developers rise as Investors react to rising flu and COVID-19 cases in the U.S. Read more ...

Analyst Mani Foroohar of Leerink Partners maintained a Sell rating on Moderna (MRNA – Research Report), reducing the price target to ...

Biopharma executives were busy Monday, striking high-value deals and providing updates on cancer, obesity and vaccine ...